Fractyl Health, Inc (GUTS) Diversifiers

Equity · Currency in USD · Last updated Jun 6, 2026

Fractyl Health, Inc. develops therapies for the treatment of type 2 diabetes (T2D) and obesity, including the Revita DMR System, an outpatient procedural therapy that modifies duodenal dysfunction, and Rejuva, a gene therapy platform aimed at enabling long-term remission of T2D and obesity by altering metabolic hormone function in pancreatic islet cells.

Looking to balance out your exposure to GUTS? The ETFs below have the lowest correlation with GUTS — they tend to move on their own, which can help reduce risk when GUTS drops. The stock ideas table highlights individual companies that behave independently from GUTS.

No Diversifiers Found for GUTS

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements GUTS

Add GUTS to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with GUTS